Literature DB >> 34239063

SARS-CoV-2 targets MAVS for immune evasion.

Alessia Zotta1, Alexander Hooftman1, Luke A J O'Neill2.   

Abstract

Entities:  

Year:  2021        PMID: 34239063     DOI: 10.1038/s41556-021-00712-y

Source DB:  PubMed          Journal:  Nat Cell Biol        ISSN: 1465-7392            Impact factor:   28.824


× No keyword cloud information.
  1 in total

1.  Targeting liquid-liquid phase separation of SARS-CoV-2 nucleocapsid protein promotes innate antiviral immunity by elevating MAVS activity.

Authors:  Shuai Wang; Tong Dai; Ziran Qin; Ting Pan; Feng Chu; Lingfeng Lou; Long Zhang; Bing Yang; Huizhe Huang; Huasong Lu; Fangfang Zhou
Journal:  Nat Cell Biol       Date:  2021-07-08       Impact factor: 28.824

  1 in total
  3 in total

Review 1.  Learning the chemical grammar of biomolecular condensates.

Authors:  Henry R Kilgore; Richard A Young
Journal:  Nat Chem Biol       Date:  2022-06-27       Impact factor: 16.174

Review 2.  SARS-CoV-2-mediated evasion strategies for antiviral interferon pathways.

Authors:  Soo-Jin Oh; Ok Sarah Shin
Journal:  J Microbiol       Date:  2022-02-05       Impact factor: 2.902

Review 3.  SARS-CoV-2: A Master of Immune Evasion.

Authors:  Alberto Rubio-Casillas; Elrashdy M Redwan; Vladimir N Uversky
Journal:  Biomedicines       Date:  2022-06-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.